Cancer News and Research

RSS

Cancer begins in your cells, which are the building blocks of your body. Normally, your body forms new cells as you need them, replacing old cells that die. Sometimes this process goes wrong. New cells grow even when you don't need them, and old cells don't die when they should. These extra cells can form a mass called a tumor. Tumors can be benign or malignant. Benign tumors aren't cancer while malignant ones are. Cells from malignant tumors can invade nearby tissues. They can also break away and spread to other parts of the body.

Research reveals how cancer cells thrive by exploiting genetic and cellular processes

Writing in EMBO reports, researchers at University of California San Diego School of Medicine and Moores Cancer Center at UC San Diego Health describe how a pair of fundamental genetic and cellular processes are exploited by cancer cells to promote tumor survival and growth.

From UC San Diego 27 Oct 2021

Correction of immune system's faulty timing may offer a new strategy to prevent severe COVID-19

Once an infection is under control, the body normally uses a biochemical messenger known as TGFβ to downgrade its immune response.

27 Oct 2021

New insight into how neurons and astrocytes work together to form healthy synapses

Brain cells called astrocytes play a key role in helping neurons develop and function properly, but there's still a lot scientists don't understand about how astrocytes perform these important jobs.

26 Oct 2021

Genetic biomarker test could help personalize therapy for men with high-risk prostate cancer

A new meta-analysis finds that a genetic biomarker test accurately predicts how men with high-risk prostate cancer will respond to treatment with radiation and hormone therapy.

26 Oct 2021

Experts use photothermal nanofibers for the safe engineering of therapeutic cells

Ghent University’s concentrated on a technique for the safe engineering of therapeutic cells with photothermal nanofibers for the past decade.

26 Oct 2021

Cell-free DNA employed to identify measurable residual disease

Researchers demonstrated that cell-free DNA from CSF could be employed to examine MRD in children treated for the brain tumor medulloblastoma.

25 Oct 2021

Scientists use DNA to create what may be the world's tiniest ruler for measuring proteins

As scientists have probed the mysteries of life down to smaller and smaller scales, they have invented tools to help them understand what they observe.

22 Oct 2021

Targeted drug shows promise against brain metastases from kidney cancer

A targeted drug has shown promising activity against brain metastases resulting from kidney cancer, achieving a 50 percent response rate, and supporting further studies of the drug in this patient group whose poor prognosis has created a significant unmet need.

22 Oct 2021

Experts develop antibodies that effectively remove senescent cells

The reason why some people age worse than others and develop diseases linked to the aging mechanism is largely unknown.

22 Oct 2021

How do large proteins and drugs cross a cell membrane?

Researchers have been wondering for several decades how molecules like proteins travel through cell walls, also called plasma membranes, without any trace.

22 Oct 2021

Study pinpoints the mutational hotspots in DNA

Recent research at the University of Bath reveals that tangles in unwound DNA can develop mutational hotspots in the genomes of bacteria.

From University of Bath 21 Oct 2021

Research illustrates the complex mechanism of bacterial innate immunity

Recent research anticipates utilizing newly characterized defense systems in bacteria to match changes to the human genome.

From Durham University 21 Oct 2021

Novel technique shows molecule conformations in live cells

Comprehending how proteins twist, bend, and shape-shift, as they work in cells, is vital to gain insights into diseases and normal biology.

21 Oct 2021

MIT researchers discover new way to awaken the immune system to attack tumors

Immunotherapy is a promising strategy to treat cancer by stimulating the body's own immune system to destroy tumor cells, but it only works for a handful of cancers. MIT researchers have now discovered a new way to jump-start the immune system to attack tumors, which they hope could allow immunotherapy to be used against more types of cancer.

From Massachusetts Institute of Technology (MIT) 20 Oct 2021

Cancer News and Research

Research reveals how cancer cells thrive by exploiting genetic and cellular processes

Correction of immune system's faulty timing may offer a new strategy to prevent severe COVID-19

New insight into how neurons and astrocytes work together to form healthy synapses

Genetic biomarker test could help personalize therapy for men with high-risk prostate cancer

Experts use photothermal nanofibers for the safe engineering of therapeutic cells

Cell-free DNA employed to identify measurable residual disease

Scientists use DNA to create what may be the world's tiniest ruler for measuring proteins

Targeted drug shows promise against brain metastases from kidney cancer

Experts develop antibodies that effectively remove senescent cells

How do large proteins and drugs cross a cell membrane?

Study pinpoints the mutational hotspots in DNA

Research illustrates the complex mechanism of bacterial innate immunity

Novel technique shows molecule conformations in live cells

MIT researchers discover new way to awaken the immune system to attack tumors

Neuroinflammation protein associated with sex-specific survival differences in glioblastoma patients

Scientists reveal the importance of circadian rhythm on the immune system

High tumor-infiltrating lymphocytes could indicate a better chance of survival in esophageal cancer

Experts discover effective means to design and build DNA nanostructures

Study identifies highly potent monoclonal antibody against all SARS-CoV-2 variants

Novel computationally modeled proteins help control cellular processes

Driving Support for Pharmaceutical Testing Through Continuous Innovation

From Memory to Metaplasticity: Unraveling the Brain's Secrets

Revolutionizing Mass Spectrometry: A Deep Dive into Plasmion’s SICRIT® Technology

Latest in Genomics